Structure (4d1e141f 24d6 41e0 A671 48ff69147297 01)
Rabeprazole Sodium Tablet, Delayed Release
Product Images NDC 13668-107
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Rabeprazole Sodium (NDC 13668-107). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (4d1e141f 24d6 41e0 A671 48ff69147297 02)
The text describes a chart showing the mean daytime heartburn scores for two groups of people taking different dosages of a medication named RAB. The dosages mentioned are 10mg and 20mg. The chart displays the study day and heartburn scores ranging from none to very severe. The text is readable.*
Figure 3 (4d1e141f 24d6 41e0 A671 48ff69147297 03)
This appears to be a figure showing the mean nighttime heartburn scores for a study involving a placebo, as well as doses of 10mg and 20mg of a medication labelled "RAB-USA-2". It also includes a key for the severity levels of heartburn, ranging from "Slight" to "Very Severe". No further information on the study or medication is provided.*
Figure 4 (4d1e141f 24d6 41e0 A671 48ff69147297 04)
The text describes a figure labeled "Figure 4" showing the mean daytime heartburn scores for RAB-USA-3. The scores are represented on a chart with the x-axis showing days and the y-axis showing the scores. The heartburn scores are described as 0 for none and 1 for slight.*
Figure 5 (4d1e141f 24d6 41e0 A671 48ff69147297 05)
This is a description of a study measuring the mean nighttime heartburn scores for a placebo group and a group taking 20mg of RAB. The study included 56 individuals in the placebo group and 53 individuals in the RAB group. The heartburn scores were recorded on study days and ranged from 0 (none) to 4 (very severe). No other information is available.*
Logo (4d1e141f 24d6 41e0 A671 48ff69147297 06)
1 (4d1e141f 24d6 41e0 A671 48ff69147297 07)
This is a description of a medication with the active ingredient Rabeprazole Sodium, contained in tablets with a strength of 20 mg. The medication is dispensed in containers with child-resistant tablets and should be stored at a temperature range of 20°C to 30°C. The text includes the manufacturer's name, TORRENT PHARMA INC., and a National Drug Code (NDC) number. There is also a note to the pharmacist to dispense the medication using a medication guide provided by Ori Pamaceutils.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
